Advertisement

Advertisement

2018 ASH Annual Meeting

Advertisement

Advertisement



Apr
10
Today In Oncology
Pre–Salvage Radiotherapy PSA Levels and Outcomes With Long-Term Antiandrogen Therapy in Prostate Cancer
Cancer Care in the Time of COVID-19 Statement From Fox Chase Cancer Center
Trastuzumab Beyond Progression in HER2-Positive Advanced Gastric/Gastroesophageal Junction Cancer
Apixaban for Cancer-Associated VTE
FDA Pipeline Approval of New Dosing for Biosimilar, Plus Two Fast Track Designations
View More 
Advertisement
Most Read Stories
Gallium-68 PSMA PET/CT Prior to Surgery or Radiotherapy in High-Risk Prostate Cancer
Pembrolizumab in Previously Treated Metastatic High-Grade Neuroendocrine Neoplasms
FDA Approves Encorafenib/Cetuximab for BRAF V600E–Mutated Metastatic Colorectal Cancer
Oncologists on the Front Lines of the COVID-19 Pandemic: A Conversation With Miriam A. Knoll, MD
ASH Research Collaborative's Data Hub Creates International Data Registry for Patients With Blood Cancers and COVID-19
View More 
Most Viewed Videos
Jeffrey A. Meyerhardt, MD, MPH, on Colon Cancer: Results From the ACTS-CC 02 Trial on Adjuvant Chemotherapy
Irene M. Ghobrial, MD, on How COVID-19 is Changing the Conduct of Clinical Trials
Neeraj Agarwal, MD, on Castration-Resistant Prostate Cancer: Results From the COSMIC-021 Study of Cabozantinib and Atezolizumab
Pirkko-Liisa Irmeli Kellokumpu-Lehtinen, MD, PhD, on Prostate Cancer: Results of the SPCG-13 Trial
Giuseppe Curigliano, MD, PhD, on How COVID-19 Is Affecting Cancer Care: The View From Italy
View More 
© 2020 HSP News Service, L.L.C.